Compound information
- Natural Products
- ZC391601
- Molecular Formula
- C12H18N2O2
- Molecular Weight
- 222.136827816 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-1-(aminomethyl)propyl]carbamate
- InChI
- InChI=1S/C12H18N2O2/c1-2-11(8-13)14-12(15)16-9-10-6-4-3-5-7-10/h3-7,11H,2,8-9,13H2,1H3,(H,14,15)/t11-/m1/s1
- InChI Key
- CWOTXZZMEPSBPP-LLVKDONJSA-N
- SMILES
- CC[C@H](CN)NC(=O)OCc1ccccc1
- Source
- ZINC000039952287
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 16 | Ring Count | 1 |
Heteroatom Count | 4 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 64.35 Å2 | LogP | 1.752 |
LogS | -1.735 | LogD | 1.711 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.042 | Pgp substrate | 0.67 |
HIA | 0.967 | F20 % | 0.993 |
F30 % | 0.337 | Caco-2 | -4.968 |
MDCK | -5.302 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.953 | PPB | 47.753 |
VD | 1.514 | Fu | 0.295 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.992 | CYP1A2 substrate | 0.722 |
CYP2A6 substrate | 0.676 | CYP2B6 substrate | 0.712 |
CYP2C19 inhibitor | 0.22 | CYP2C19 substrate | 0.766 |
CYP2C8 substrate | 0.72 | CYP2C9 inhibitor | 0.037 |
CYP2C9 substrate | 0.971 | CYP2D6 inhibitor | 0.212 |
CYP2D6 substrate | 0.995 | CYP2E1 substrate | 0.449 |
CYP3A4 inhibitor | 0.197 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.639 | CL | 5.336 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.209 | Hepatotoxicity | 0.729 |
Mutagenicity | 0.886 | Rat Oral Acute Toxicity | 0.131 |
FDAMDD | 0.348 | Skin Sensitization | 0.6 |
Carcinogenicity | 0.09 | Eye Corrosion | 0.024 |
Eye Irritation | 0.039 | Respiratory Toxicity | 0.631 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.004 | IGC50 | 2.697 |
LC50FM | 3.396 | LC50DM | 5.083 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.103 | NR-AR-LBD | 0.201 |
NR-AhR | 0.003 | NR-Aromatase | 0.028 |
NR-ER | 0.269 | NR-ER-LBD | 0.278 |
NR-PPAR-gamma | 0.168 | SR-ARE | 0.034 |
SR-ATAD5 | 0.294 | SR-HSE | 0.096 |
SR-MMP | 0.006 | SR-p53 | 0.014 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.